Asthma Clinical Trials

Showing 3941-3960 of 4,312 trials

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

NCT00685022

The purpose of this study is to compare the safety and tolerability of levalbuterol HFA metered dose inhaler (MDI) versus racemic albuterol HFA MDI.

Asthma

Sumitomo Pharma America, Inc.49 participantsStarted Jun 2003

Encinitas, California, United States • North Dartmouth, Massachusetts, United States • St Louis, Missouri, United States

COMPLETED

Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma Remission

NCT00526019

This study aims at determining the patterns of asthma remission, the prevalence of these different patterns, the various factors associated with such remissions and possible recurrences of asthma, in order to determine the mechanisms involved in these processes. The investigators therefore want to document these specificities in subjects in complete remission of their asthma, and those in only symptomatic remission of their asthma, in comparison with mildly symptomatic asthmatic subjects and healthy controls.

Asthma

Laval University85 participantsStarted Sep 2007

COMPLETEDPhase 3

Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma

NCT00064389

The purpose of this study is to evaluate the safety of levalbuterol as compared to racemic albuterol based on the frequencies of adverse events reporting during a 12-month period of chronic dosing of adolescent and adult subjects with asthma.

Asthma

Sumitomo Pharma America, Inc.746 participantsStarted Jan 2003

Birmington, Alabama, United States • Mobile, Alabama, United States • Montgomery, Alabama, United States +93 more locations

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma Remission

Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma

Related Searches

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma

Coping Skills Training (CST) for Children With Chronic Health Conditions

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

Will CPAP Reduce Length Of Respiratory Support In Premature Infants?

Pressure-limited Ventilation Versus Volume-targeted Ventilation in Preterm Newborns

The Use of Fractional Exhaled Nitric Oxide in the Identification of Non-adherence in Difficult Asthma

Withdrawal of Non-invasive Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Acute Hypercapnic Respiratory Failure

Fibreoptic Intubation With and Without Sellick´s Maneuver

Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe Asthma

Comparison of Two Treatment Regimens in Asthmatic Patients

Effect of Montelukast on the Airway Remodeling

Bacille Calmette-Guérin (BCG) Vaccine and Atopy

Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

Electronic Health Record (EHR) Decision Support to Improve Outpatient Asthma Care

Budesonide for Emergency Treatment of Acute Wheezing in Children